https://www.nxtpsychedelics.com/news/articles/psychedelics/beckley-psytech-announces-first-participant-dosed-in-phase-i-trial-of-ele-101-a-novel-intravenous-formulation-of-psilocin/
Beckley Psytech Announces First Participant Dosed in Phase I Trial of ELE-101, A Novel Intravenous Formulation of Psilocin